Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Other

Organigram launches Edison, Boxhot in Australia

By The Northwire Desk — AI Analysis Feb 24, 2026 · 11:33 OGI · 1.95 Organigram Global Inc
OGI · Price

Executive Summary

  • Organigram Global Inc. has launched its Edison and Boxhot medical cannabis vape and pastille products in the Australian market, expanding its international portfolio beyond its existing B2B flower supply.
  • The launch coincides with the company's proposed acquisition of Sanity Group, a leading German cannabis company, marking a significant step in Organigram's global expansion strategy.
  • Products will be distributed through a partnership with Leafio (Montu Australia), making them available to over 4,000 pharmacies nationwide.

Key Details

  • Product Launch: Introduction of 10 new product SKUs across two brands:
    • Edison: Vapes featuring single-strain live terpenes extracted from Canada's top-selling cultivars (terpenes shipped to Australia) and pastilles with established formulations for specific patient experiences.
    • Boxhot: Botanical blends in proprietary wide-bodied 1.2-gram cartridges, featuring three of the top-selling blends in Canada.
  • Distribution: Partnership with Leafio, the wholesale distribution arm of Montu Australia, to supply products to more than 4,000 pharmacies via Leafio's nationwide supply chain.
  • Strategic Context: The launch is described as coinciding with the proposed acquisition of Sanity Group (Germany), reinforcing Organigram's commitment to broadening its global reach.
  • Market Positioning: Focus on "ready-to-consume" formats (vapes and pastilles) driven by demand for consistent dosing, ease of administration, and discreet formats, complementing existing flower sales.
  • Marketing/Events: Organigram is sponsoring the United in Compassion (UIC) Medical Cannabis Symposium in Brisbane (Feb. 26–28), where SVP Borna Zlamalik will speak on scientific validation and product confidence.

Notable Quotes

  • Megan McCrae, Senior Vice President, Corporate Strategy and International Growth: "Australia represents an exciting international opportunity in medical cannabis, and we are entering the market at a pivotal moment with an informed strategy. The launch of Organigram brands in Australia coincides with our proposed acquisition of Sanity Group... marking a significant step in our international expansion."
  • Borna Zlamalik, Senior Vice-President, Innovation and International Research and Development: "Australia is a rapidly evolving medical market where we see momentum in ready-to-consume formats beyond traditional flower... Our industry-leading focus on science and clinical validation -- combined with our experience developing high-quality, non-flower products in Canada -- give us a unique advantage as we introduce our established Canadian brands and product offerings to the Australian market."
Read the original news release →

More from Organigram Global Inc

May 14, 2026 · 08:45

Organigram Left Watching as European Cannabis Boom Accelerates, Q2 Miss Deepens Share Slide

M&A / Property May 12, 2026 · 06:00

Organigram’s core Canadian business stumbles into the red just as its landmark Sanity Group deal closes, leaving investors to wonder if the European cure will be enough to offset domestic decay.

Earnings Apr 15, 2026 · 12:03

Organigram Executes Europe Pivot as BAT Deal Closes, Dilution Looms

Financings Mar 30, 2026 · 20:30

Organigram Clears Final Hurdle for Sanity Acquisition as Dilution and Cash Constraints Loom

Financings Mar 23, 2026 · 14:07

Organigram garners ISS support for Sanity transaction

M&A / Property Mar 23, 2026 · 06:00

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

M&A / Property